DRAXIMAGE MAA DIN 02329417
Health Canada record
| Active ingredient(s) | ALBUMIN 2.5 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | B05AA01 ALBUMIN |
| Original market date | 05-Dec-1972 |
| Current status date | 21-Aug-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jubilant Draximage Inc. dba Jubilant Radiopharma — licence 101869, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALBUMIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00779571 | ALBUTEIN 25% SOLN USP | GRIFOLS BIOLOGICALS LLC | Solution | ALBUMIN 250 MG | Dormant |
| 00779563 | ALBUTEIN 5% SOLN USP | GRIFOLS BIOLOGICALS LLC | Solution | ALBUMIN 50 MG | Dormant |
| 00769932 | HUMANALBIN INJ 5% | BEHRINGWERKE AG | Liquid | ALBUMIN 50 MG | Cancelled Post Market |
| 00438278 | PLASBUMIN-5 INJ 50MG/ML | CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD. | Liquid | ALBUMIN 50 MG | Cancelled Post Market |
International API supply for ALBUMIN
6 active FDA Drug Master Files.
Request a quote for DRAXIMAGE MAA